ENTRY       N00282                      Network
NAME        EREG-EGFR-PI3K signaling pathway
DEFINITION  EREG -> EGFR -> PI3K -> PIP3 -> AKT -> MTOR -> S6K
  EXPANDED  2069 -> 1956 -> (5290,5291,5293) -> C05981 -> (207,208,10000) -> 2475 -> (6198,6199)
CLASS       nt06214 PI3K signaling
            nt06260 Colorectal cancer
TYPE        Reference
PATHWAY     hsa04012  ErbB signaling pathway
            hsa04151  PI3K-Akt signaling pathway
GENE        2069  EREG; epiregulin
            1956  EGFR; epidermal growth factor receptor
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
            207  AKT1; AKT serine/threonine kinase 1
            208  AKT2; AKT serine/threonine kinase 2
            10000  AKT3; AKT serine/threonine kinase 3
            2475  MTOR; mechanistic target of rapamycin kinase
            6198  RPS6KB1; ribosomal protein S6 kinase B1
            6199  RPS6KB2; ribosomal protein S6 kinase B2
METABOLITE  C05981  Phosphatidylinositol-3,4,5-trisphosphate
REFERENCE   PMID:14967450
  AUTHORS   Marmor MD, Skaria KB, Yarden Y.
  TITLE     Signal transduction and oncogenesis by ErbB/HER receptors.
  JOURNAL   Int J Radiat Oncol Biol Phys 58:903-13 (2004)
            DOI:10.1016/j.ijrobp.2003.06.002
REFERENCE   PMID:17000658
  AUTHORS   Scaltriti M, Baselga J.
  TITLE     The epidermal growth factor receptor pathway: a model for targeted therapy.
  JOURNAL   Clin Cancer Res 12:5268-72 (2006)
            DOI:10.1158/1078-0432.CCR-05-1554
///
